ARCHIVES

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

This article is from The Cancer Letter archive.

Vol. 32 No. 02 | January 20, 2006

Download PDF Visit The Full Archive

Related Articles

Congress Funds NIH Through Fiscal Year, Re-Opening Agency With 5.7% Increase

January 12, 1996

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Ohio State Breaks Ground For $1 Billion Expansion Of Medical Center, Cancer Hospital

June 18, 2010

NCI Study Finds No Greater Cancer Risk Near Nuclear Plants

September 28, 1990

Agents Not Indicated In Curative Setting.

August 8, 2008

Price Increase

July 22, 1983